Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma
Clinical trial NCT02363283 · COMPLETED
Trial details
- NCT number
- NCT02363283
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-16
- Primary completion
- 2018-07-02
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.